-
公开(公告)号:US07297695B2
公开(公告)日:2007-11-20
申请号:US11426479
申请日:2006-06-26
申请人: Brian E. Fink , Ashvinikumar V. Gavai , Gregory D. Vite , Ping Chen , Harold Mastalerz , Derek J. Norris , John S. Tokarski , Yufen Zhao , Wen-Ching Han
发明人: Brian E. Fink , Ashvinikumar V. Gavai , Gregory D. Vite , Ping Chen , Harold Mastalerz , Derek J. Norris , John S. Tokarski , Yufen Zhao , Wen-Ching Han
IPC分类号: C07D487/04 , C07D401/06 , C07D401/14 , A61K31/53 , A61P35/00
CPC分类号: C07D487/04
摘要: The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of growth factor receptors such as HER1, HER2 and HER4 thereby making them useful as antiproliferative agents. The formula I compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.
摘要翻译: 本发明提供式I化合物及其药学上可接受的盐。 式I化合物抑制生长因子受体如HER1,HER2和HER4的酪氨酸激酶活性,从而使其成为抗增殖剂。 式I化合物还可用于治疗与通过生长因子受体操作的信号转导途径相关的其它疾病。
-
公开(公告)号:US20110039838A1
公开(公告)日:2011-02-17
申请号:US12911299
申请日:2010-10-25
申请人: Brian E. Fink , Ashvinikumar V. Gavai , Gregory D. Vite , Ping Chen , Harold Mastalerz , Derek J. Norris , John S. Tokarski , Yufen Zhao , Wen-Ching Han
发明人: Brian E. Fink , Ashvinikumar V. Gavai , Gregory D. Vite , Ping Chen , Harold Mastalerz , Derek J. Norris , John S. Tokarski , Yufen Zhao , Wen-Ching Han
IPC分类号: A61K31/53 , C07D487/04 , A61K31/5377 , C07D498/04 , A61K31/5383 , A61P35/00 , A61P17/06 , A61P29/00 , G01N33/53
CPC分类号: C07D487/04
摘要: The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof.The formula I compounds inhibit tyrosine kinase activity of growth factor receptors such as HER1, HER2 and HER4 thereby making them useful as antiproliferative agents. The formula I compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.
摘要翻译: 本发明提供式I化合物及其药学上可接受的盐。 式I化合物抑制生长因子受体如HER1,HER2和HER4的酪氨酸激酶活性,从而使其成为抗增殖剂。 式I化合物还可用于治疗与通过生长因子受体操作的信号转导途径相关的其它疾病。
-
公开(公告)号:US20100081662A1
公开(公告)日:2010-04-01
申请号:US12447751
申请日:2007-11-02
申请人: Brian E. Fink , Ping Chen
发明人: Brian E. Fink , Ping Chen
IPC分类号: A61K31/53 , C07D487/04 , A61P35/00
CPC分类号: C07D487/04
摘要: The invention provides compounds of formula I and pharmaceutically acceptable salts thereof.The formula I compounds inhibit tyrosine kinase activity of Trk receptors such as TrkA, TrkB, TrkC or Flt-3 thereby making them useful as anticancer agents.
摘要翻译: 本发明提供式I化合物及其药学上可接受的盐。 式I化合物抑制Trk受体如TrkA,TrkB,TrkC或Flt-3的酪氨酸激酶活性,从而使其成为抗癌剂。
-
公开(公告)号:US07605160B2
公开(公告)日:2009-10-20
申请号:US11835469
申请日:2007-08-08
申请人: Brian E. Fink , Ping Chen
发明人: Brian E. Fink , Ping Chen
IPC分类号: C07D487/04 , C07D403/12 , C07D403/14 , A61K31/53 , A61P19/02 , A61P35/00
CPC分类号: C07D487/04
摘要: The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of Trk receptors such as TrkA, TrkB and TrkC thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.
摘要翻译: 本发明提供式I化合物及其药学上可接受的盐。 式I化合物抑制Trk受体如TrkA,TrkB和TrkC的酪氨酸激酶活性,从而使它们可用作治疗癌症和其它疾病的抗增殖剂。
-
公开(公告)号:US07531539B2
公开(公告)日:2009-05-12
申请号:US11835456
申请日:2007-08-08
申请人: Brian E. Fink , Ping Chen , Ashok Vinayak Purandare , Honghe Wan
发明人: Brian E. Fink , Ping Chen , Ashok Vinayak Purandare , Honghe Wan
IPC分类号: C07D487/04 , C07D403/12 , C07D403/14 , A61K31/53 , A61P19/02 , A61P35/00
CPC分类号: C07D487/04
摘要: The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of such as TrkA, TrkB, TrkC, Jak2, Jak3 and CK2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.
摘要翻译: 本发明提供式I化合物及其药学上可接受的盐。 式I化合物抑制TrkA,TrkB,TrkC,Jak2,Jak3和CK2的酪氨酸激酶活性,从而使其成为用于治疗癌症和其它疾病的抗增生剂。
-
公开(公告)号:US20090048244A1
公开(公告)日:2009-02-19
申请号:US11869910
申请日:2008-09-24
申请人: Brian E. Fink , Ashvinikumar V. Gavai , Gregory D. Vite , Ping Chen , Harold Mastalerz , Derek J. Norris , John S. Tokarski , Yufen Zhao , Wen-Ching Han
发明人: Brian E. Fink , Ashvinikumar V. Gavai , Gregory D. Vite , Ping Chen , Harold Mastalerz , Derek J. Norris , John S. Tokarski , Yufen Zhao , Wen-Ching Han
IPC分类号: A61K31/5377 , A61K31/53 , A61P35/00
CPC分类号: C07D487/04
摘要: The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof.The formula I compounds inhibit tyrosine kinase activity of growth factor receptors such as HER1, HER2 and HER4 thereby making them useful as antiproliferative agents. The formula I compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.
摘要翻译: 本发明提供式I化合物及其药学上可接受的盐。 式I化合物抑制生长因子受体如HER1,HER2和HER4的酪氨酸激酶活性,从而使其成为抗增殖剂。 式I化合物还可用于治疗与通过生长因子受体操作的信号转导途径相关的其它疾病。
-
公开(公告)号:US08389527B2
公开(公告)日:2013-03-05
申请号:US12866365
申请日:2009-02-06
申请人: Brian E. Fink , Soong-Hoon Kim , Yufen Zhao , Ping Chen , Wayne Vaccaro , Litai Zhang , Ashvinikumar V Gavai , Dharmpal S Dodd , Libing Chen
发明人: Brian E. Fink , Soong-Hoon Kim , Yufen Zhao , Ping Chen , Wayne Vaccaro , Litai Zhang , Ashvinikumar V Gavai , Dharmpal S Dodd , Libing Chen
IPC分类号: A01N43/58 , A01N43/60 , C61K31/50 , C07D487/00
CPC分类号: C07D487/04
摘要: The invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I imidazopyridazines inhibit protein kinase activity thereby making them useful as anticancer agents.
摘要翻译: 本发明提供式I化合物及其药学上可接受的盐。 式I咪唑并哒嗪抑制蛋白激酶活性,从而使其成为抗癌剂。
-
公开(公告)号:US20100323994A1
公开(公告)日:2010-12-23
申请号:US12866365
申请日:2009-02-06
申请人: Brian E. Fink , Soong-Hoon Kim , Yufen Zhao , Ping Chen , Wayne Vaccaro , Litai Zhang , Ashvinikumar V. Gaval , Dharmpal S. Dodd , Libing Chen
发明人: Brian E. Fink , Soong-Hoon Kim , Yufen Zhao , Ping Chen , Wayne Vaccaro , Litai Zhang , Ashvinikumar V. Gaval , Dharmpal S. Dodd , Libing Chen
IPC分类号: A61K31/5025 , C07D487/04 , A61K31/5377 , A61K31/55 , A61K31/551 , A61K31/397 , A61P35/00 , A61P17/06 , A61P19/02
CPC分类号: C07D487/04
摘要: The invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I imidazopyridazines inhibit protein kinase activity thereby making them useful as anticancer agents.
摘要翻译: 本发明提供式I化合物及其药学上可接受的盐。 式I咪唑并哒嗪抑制蛋白激酶活性,从而使其成为抗癌剂。
-
公开(公告)号:US07141571B2
公开(公告)日:2006-11-28
申请号:US11019901
申请日:2004-12-22
申请人: Brian E. Fink , Ashvinikumar V. Gavai , Gregory D. Vite , Ping Chen , Harold Mastalerz , Derek J. Norris , John S. Tokarski , Yufen Zhao , Wen-Ching Han
发明人: Brian E. Fink , Ashvinikumar V. Gavai , Gregory D. Vite , Ping Chen , Harold Mastalerz , Derek J. Norris , John S. Tokarski , Yufen Zhao , Wen-Ching Han
IPC分类号: C07D487/04 , A61K31/53
CPC分类号: C07D487/04
摘要: The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of growth factor receptors such as HER1, HER2 and HER4 thereby making them useful as antiproliferative agents. The formula I compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.
摘要翻译: 本发明提供式I化合物及其药学上可接受的盐。 式I化合物抑制生长因子受体如HER1,HER2和HER4的酪氨酸激酶活性,从而使其成为抗增殖剂。 式I化合物还可用于治疗与通过生长因子受体操作的信号转导途径相关的其它疾病。
-
公开(公告)号:US20110245252A1
公开(公告)日:2011-10-06
申请号:US13159739
申请日:2011-06-14
申请人: Brian E. Fink , Ping Chen
发明人: Brian E. Fink , Ping Chen
IPC分类号: A61K31/53 , C07D487/04 , A61P35/00
CPC分类号: C07D487/04 , A61K31/53
摘要: The invention provides compounds of formula I and pharmaceutically acceptable salts thereof.The formula I compounds inhibit tyrosine kinase activity of Trk receptors such as TrkA, TrkB, TrkC or Flt-3 thereby making them useful as anticancer agents.
摘要翻译: 本发明提供式I化合物及其药学上可接受的盐。 式I化合物抑制Trk受体如TrkA,TrkB,TrkC或Flt-3的酪氨酸激酶活性,从而使其成为抗癌剂。
-
-
-
-
-
-
-
-
-